These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37150426)

  • 1. Utilization and Cost of Outpatient Rehabilitation Services for Pediatric Patients Treated for Acute Lymphoblastic Leukemia Using a Commercial Claims Database.
    Gilchrist L; Tanner L; Finch M; Watson D; Hoover A; Turcotte L; Messinger Y
    Arch Phys Med Rehabil; 2023 Nov; 104(11):1857-1864. PubMed ID: 37150426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Cost of Pediatric Acute Lymphoblastic Leukemia Care Among Commercially Insured Individuals in the United States: Effect of Era and Age at Diagnosis.
    Turcotte LM; Watson D; Tanner L; Hoover A; Gilchrist L; Finch M; Messinger YH
    JCO Oncol Pract; 2022 Nov; 18(11):e1750-e1761. PubMed ID: 36166724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource utilization for chronic low back pain among high-utilizers.
    Kirsch EP; Yang LZ; Lee HJ; Parente B; Lad SP
    Spine J; 2024 Apr; 24(4):601-616. PubMed ID: 38081464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis.
    Hoover A; Reimche P; Watson D; Tanner L; Gilchrist L; Finch M; Messinger YH; Turcotte LM
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1980. PubMed ID: 38217445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expenditures among young adults with acute lymphoblastic leukemia by site of care.
    Wolfson JA; Bhatia S; Ginsberg J; Becker LK; Bernstein D; Henk HJ; Lyman GH; Nathan PC; Puccetti D; Wilkes JJ; Winestone LE; Kenzik KM
    Cancer; 2021 Jun; 127(11):1901-1911. PubMed ID: 33465248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL.
    Hoover A; Watson D; Reimche P; Tanner L; Gilchrist L; Finch M; Messinger YH; Turcotte LM
    BMC Res Notes; 2024 Apr; 17(1):112. PubMed ID: 38644484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the Initial Outpatient Rehabilitation Utilization for Patients With Total Knee Arthroplasty.
    Lee MJ; Tucker CA; Fisher SR; Tahashilder MI; Prichard KT; Kuo YF
    Arch Phys Med Rehabil; 2023 Nov; 104(11):1812-1819.e6. PubMed ID: 37119952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
    Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
    J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in outpatient and home health service utilization following stroke: results of a 9-year cohort study in Northern California.
    Chan L; Wang H; Terdiman J; Hoffman J; Ciol MA; Lattimore BF; Sidney S; Quesenberry C; Lu Q; Sandel ME
    PM R; 2009 Nov; 1(11):997-1003. PubMed ID: 19942185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
    Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
    Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost associated with stroke: outpatient rehabilitative services and medication.
    Godwin KM; Wasserman J; Ostwald SK
    Top Stroke Rehabil; 2011 Oct; 18 Suppl 1():676-84. PubMed ID: 22120036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome.
    Athale U; Sutradhar R; Breakey VR; Li Q; Bassal M; Gibson P; Patel S; Wheaton L; Pole JD; Mittman N; Pechlivanoglou P; Gupta S
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29829. PubMed ID: 35674471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients.
    Heun-Johnson H; Menchine M; Axeen S; Lung K; Claudius I; Wright T; Seabury SA
    JAMA Psychiatry; 2021 Mar; 78(3):311-319. PubMed ID: 33355626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
    Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
    J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada.
    Gupta S; Sutradhar R; Li Q; Athale U; Bassal M; Breakey V; Gibson PJ; Patel S; Silva M; Zabih V; Pechlivanoglou P; Pole JD; Mittmann N
    Eur J Cancer; 2021 Jul; 151():126-135. PubMed ID: 33979728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study.
    Elsaid MI; John T; Li Y; Koduru S; Ali SZ; Catalano C; Narayanan N; Rustgi VK
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1377-1386. PubMed ID: 31778618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monetary costs of pediatric upper urinary tract stone disease: Analysis in a contemporary United States cohort.
    Sturgis MR; Becerra AZ; Khusid JA; Fink LE; Roadman DF; Ross JH; Gupta M; Konety BR; Olweny EO
    J Pediatr Urol; 2022 Jun; 18(3):311.e1-311.e8. PubMed ID: 35314112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Health Care Utilization With Rates of Perforated Appendicitis in Children 18 Years or Younger.
    Baxter KJ; Nguyen HTMH; Wulkan ML; Raval MV
    JAMA Surg; 2018 Jun; 153(6):544-550. PubMed ID: 29387882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.